[FATE] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
02-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -6.36%
YoY- -76.59%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 44,356 17,067 15,896 2,802 1,661 1,027 1,027 87.25%
PBT -56,363 -68,621 -53,112 -28,302 -16,027 -12,497 -7,940 38.61%
Tax -8,056 -2,206 -861 691 817 -131 -160 92.10%
NP -48,307 -68,621 -53,112 -28,302 -16,027 -12,497 -7,940 35.09%
Tax Rate - - - - - - - -
Total Cost 92,663 85,688 69,008 31,104 17,688 13,524 8,967 47.55%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -108.91 -402.07 -334.12 -1,010.06 -964.90 -1,216.85 -773.13 -27.85%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.50 -0.72 -0.61 -0.37 -0.25 -0.29 -0.21 15.54%
EPS Diluted -0.50 -0.72 -0.61 -0.37 -0.25 -0.29 -0.21 15.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.